DIVI'S LABORATORIES LTD. - 532488 - Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2022
Further to our intimation dated July 28, 2022, we would like to inform that the Board of Directors of the Company at its meeting held on Friday, August 12, 2022 has approved the Unaudited Financial Results for the quarter ended June 30, 2022. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following: 1. Statement of Standalone Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon. 2. Statement of Consolidated Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon. 3. Press Release on the Financial Results of the Company. The Board meeting commenced at 11.00 Hrs and concluded at 12.15 Hrs12-08-2022